Tags

Type your tag names separated by a space and hit enter

Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum.
J Allergy Clin Immunol. 2006 May; 117(5):1113-7.JA

Abstract

BACKGROUND

Several aspects of the pathogenesis of chronic urticaria (CU) remain contradictory. Autologous serum skin tests (ASSTs) and in vitro histamine release assays seem to look into distinct aspects of the disease, and the specificity of ASST has been questioned.

OBJECTIVE

We compared the autologous plasma skin test (APST) with ASST to detect autoreactivity in patients with CU. The clotting process was investigated as well by measuring in vivo thrombin generation.

METHODS

A total of 96 adults with CU underwent ASST; 71 of them underwent APST with Na citrate-anticoagulated plasma. Prothrombin fragment 1+2 plasma levels were measured by a sandwich ELISA in Na citrate-anticoagulated plasmas from 28 patients and 27 controls.

RESULTS

Fifty-one of 96 (53%) patients scored positive on ASST, whereas 61 of 71 (86%) patients scored positive on APST (21/30 [70%] ASST-negative and 40/41 [98%] ASST-positive). Plasma prothrombin fragment 1+2 was higher in patients than controls (3.06 [SD 3.36] vs 0.80 [0.34]; P < .001) and in ASST-positive/APST-positive than in ASST-negative/APST-positive patients (3.89 [SD 3.68] vs 1.33 [1.64]; P = 0.058) and was directly related to urticaria severity (r = 0.37; P < .05).

CONCLUSION

Most patients with CU are positive on APST-Na citrate. CU is associated with the generation of thrombin, a serine protease able to activate mast cells and to cause relevant increase in permeability of endothelium. APST and ASST only partially depend on the presence of circulating antibodies to FcepsilonRI or to IgE.

CLINICAL IMPLICATIONS

These findings provide new insights into the pathogenesis of CU and suggest new therapeutic opportunities for treating this disease.

Authors+Show Affiliations

Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy. r.asero@libero.itNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

16675340

Citation

Asero, Riccardo, et al. "Plasma of Patients With Chronic Urticaria Shows Signs of Thrombin Generation, and Its Intradermal Injection Causes Wheal-and-flare Reactions Much More Frequently Than Autologous Serum." The Journal of Allergy and Clinical Immunology, vol. 117, no. 5, 2006, pp. 1113-7.
Asero R, Tedeschi A, Riboldi P, et al. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol. 2006;117(5):1113-7.
Asero, R., Tedeschi, A., Riboldi, P., & Cugno, M. (2006). Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. The Journal of Allergy and Clinical Immunology, 117(5), 1113-7.
Asero R, et al. Plasma of Patients With Chronic Urticaria Shows Signs of Thrombin Generation, and Its Intradermal Injection Causes Wheal-and-flare Reactions Much More Frequently Than Autologous Serum. J Allergy Clin Immunol. 2006;117(5):1113-7. PubMed PMID: 16675340.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. AU - Asero,Riccardo, AU - Tedeschi,Alberto, AU - Riboldi,Piersandro, AU - Cugno,Massimo, Y1 - 2006/02/14/ PY - 2005/10/18/received PY - 2005/12/21/revised PY - 2005/12/22/accepted PY - 2006/5/6/pubmed PY - 2006/6/8/medline PY - 2006/5/6/entrez SP - 1113 EP - 7 JF - The Journal of allergy and clinical immunology JO - J Allergy Clin Immunol VL - 117 IS - 5 N2 - BACKGROUND: Several aspects of the pathogenesis of chronic urticaria (CU) remain contradictory. Autologous serum skin tests (ASSTs) and in vitro histamine release assays seem to look into distinct aspects of the disease, and the specificity of ASST has been questioned. OBJECTIVE: We compared the autologous plasma skin test (APST) with ASST to detect autoreactivity in patients with CU. The clotting process was investigated as well by measuring in vivo thrombin generation. METHODS: A total of 96 adults with CU underwent ASST; 71 of them underwent APST with Na citrate-anticoagulated plasma. Prothrombin fragment 1+2 plasma levels were measured by a sandwich ELISA in Na citrate-anticoagulated plasmas from 28 patients and 27 controls. RESULTS: Fifty-one of 96 (53%) patients scored positive on ASST, whereas 61 of 71 (86%) patients scored positive on APST (21/30 [70%] ASST-negative and 40/41 [98%] ASST-positive). Plasma prothrombin fragment 1+2 was higher in patients than controls (3.06 [SD 3.36] vs 0.80 [0.34]; P < .001) and in ASST-positive/APST-positive than in ASST-negative/APST-positive patients (3.89 [SD 3.68] vs 1.33 [1.64]; P = 0.058) and was directly related to urticaria severity (r = 0.37; P < .05). CONCLUSION: Most patients with CU are positive on APST-Na citrate. CU is associated with the generation of thrombin, a serine protease able to activate mast cells and to cause relevant increase in permeability of endothelium. APST and ASST only partially depend on the presence of circulating antibodies to FcepsilonRI or to IgE. CLINICAL IMPLICATIONS: These findings provide new insights into the pathogenesis of CU and suggest new therapeutic opportunities for treating this disease. SN - 0091-6749 UR - https://www.unboundmedicine.com/medline/citation/16675340/Plasma_of_patients_with_chronic_urticaria_shows_signs_of_thrombin_generation_and_its_intradermal_injection_causes_wheal_and_flare_reactions_much_more_frequently_than_autologous_serum_ DB - PRIME DP - Unbound Medicine ER -